My Documents
Become a Patron!
# Lovenox bridge protocol pdf **
Rating: 4.4 / 5 (1783 votes)
Downloads: 47500
CLICK HERE TO DOWNLOAD
**
For patients with obesity receiving LMWH therapy for treatment of VTE, the ASH guideline panel suggests against using anti–factor Xa concentration There is no standardized bridging drug or dose. rease in thromboembolic events when bridging is used.5,The estimated perioperative risk of symptomatic thromboembolic events in patients with MHVs who undergo bridging is about % to %,6,8 with higher rates noted for cage-ball valves and tilting disc valves that have since been retiredWithout bridging, thromboem- as recommended in product labeling (e.g., enoxaparin) or switching to an alternative anticoagulant with lower renal clearance, such as unfractionated heparin (UFH) or a different LMWH. Traditional Enoxaparin (Lovenox) Lovenox Discontinuation Plan In patients who are receiving bridge Last preoperative dose approximatelyhours before surgery(UFH) IV UFH Bridging: The use of a(n) subcutaneous or intravenous anticoagulant for a period of time during interruption of warfarin therapy and/or when the INR is not within a therapeutic range Alternative Drugs for Bridging Drug Therapeutic Dose Prophylaxis Dose Pre-Surgery Regimen Enoxaparin (Lovenox)mg/kg SQ BID or mg/kg SQ dailymg SQ BID ormg SQ daily Last dosehr prior to surgery Enoxaparin for chronic kidney disease 1mg/kg SQ daily when CrCl